Investigating the association between a history of depression and biomarkers of Alzheimer’s disease, cerebrovascular disease, and neurodegeneration in patients with dementia

被引:0
作者
Patrick Salwierz
Simrika Thapa
Foad Taghdiri
Anna Vasilevskaya
Chloe Anastassiadis
David F. Tang-Wai
Angela C. Golas
M. Carmela Tartaglia
机构
[1] University of Toronto,Tanz Centre for Research in Neurodegenerative Diseases, Temerty Faculty of Medicine
[2] University of Toronto,Division of Neurology, Department of Medicine
[3] Memory Clinic University Health Network,Department of Psychiatry, Temerty Faculty of Medicine
[4] Krembil Brain Institute,undefined
[5] Centre for Addiction and Mental Health,undefined
[6] University of Toronto,undefined
来源
GeroScience | 2024年 / 46卷
关键词
Major depressive disorder; Alzheimer’s disease; Cerebrovascular disease; Cerebrospinal fluid biomarkers; White matter hyperintensities;
D O I
暂无
中图分类号
学科分类号
摘要
The association between depression and dementia, particularly Alzheimer’s disease (AD) and cerebrovascular disease (CVD), remains an active area of research. This study aimed to investigate the relationship between a history of depression and biomarkers of AD and CVD in patients with dementia in a clinical setting. A total of 126 patients from the University Health Network (UHN) Memory Clinic with comprehensive clinical evaluations, including neuropsychological testing and medical examinations, were included. Lumbar puncture was performed to collect cerebrospinal fluid (CSF) for biomarker analysis, and brain magnetic resonance imaging (MRI) scans were obtained to assess white matter hyperintensity (WMH) burden. The presence of depression was determined through medical records. The study findings did not reveal significant differences between participants with and without a history of depression in terms of AD biomarkers, WMH burden, neurofilament light chain levels, cognitive scores, age of symptom onset, disease duration, or vascular risk scores. Logistic regression analysis did not indicate a meaningful predictive value of these variables for depression status. This clinical study contributes to our understanding regarding the association between depression and AD/CVD biomarkers in patients with cognitive impairment. Further research is needed to elucidate the complex relationship between depression and dementia and to explore the potential mechanisms linking depression, AD, and CVD.
引用
收藏
页码:783 / 793
页数:10
相关论文
共 50 条
  • [41] Biomarkers in Alzheimer's disease
    Garcia-Ribas, Guillermo
    Lopez-Sendon Moreno, Jose Luis
    Garcia-Caldentey, Juan
    REVISTA DE NEUROLOGIA, 2014, 58 (07) : 308 - 317
  • [42] Depression as a Risk Factor for Dementia and Alzheimer's Disease
    Canton-Habas, Vanesa
    Rich-Ruiz, Manuel
    Romero-Saldana, Manuel
    Carrera-Gonzalez, Maria del Pilar
    BIOMEDICINES, 2020, 8 (11) : 1 - 15
  • [43] Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy
    Chouliaras, Leonidas
    Thomas, Alan
    Malpetti, Maura
    Donaghy, Paul
    Kane, Joseph
    Mak, Elijah
    Savulich, George
    Prats-Sedano, Maria A.
    Heslegrave, Amanda J.
    Zetterberg, Henrik
    Su, Li
    Rowe, James Benedict
    O'Brien, John Tiernan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, : 651 - 658
  • [44] Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals
    Pettigrew, Corinne
    Soldan, Anja
    Zhu, Yuxin
    Cai, Qing
    Wang, Mei-Cheng
    Moghekar, Abhay
    Miller, Michael, I
    Singh, Baljeet
    Martinez, Oliver
    Fletcher, Evan
    DeCarli, Charles
    Albert, Marilyn
    NEUROBIOLOGY OF AGING, 2020, 88 : 33 - 41
  • [45] Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease
    Park, J. H.
    Lee, S. B.
    Lee, T. J.
    Lee, D. Y.
    Jhoo, J. H.
    Youn, J. C.
    Choo, I. H.
    Choi, E. A.
    Jeong, J. W.
    Choe, J. Y.
    Woo, J. I.
    Kim, K. W.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 23 (02) : 67 - 73
  • [46] Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals
    Sun, Qingling
    Ni, Jingnian
    Wei, Mingqing
    Long, Siwei
    Li, Ting
    Fan, Dongsheng
    Lu, Tao
    Shi, Jing
    Tian, Jinzhou
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [47] Exploring the effect of APOE ε 4 on biomarkers of neurodegeneration in Alzheimer's ' s disease
    Agnello, Luisa
    Gambino, Caterina Maria
    Ciaccio, Anna Maria
    Piccoli, Tommaso
    Blandino, Valeria
    Scazzone, Concetta
    Lo Sasso, Bruna
    Del Ben, Fabio
    Ciaccio, Marcello
    CLINICA CHIMICA ACTA, 2024, 562
  • [48] Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia
    Di Rosa, Michelino
    Dell'Ombra, Nicola
    Zambito, Anna Maria
    Malaguarnera, Mariano
    Nicoletti, Ferdinando
    Malaguamera, Lucia
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 23 (10) : 2648 - 2656
  • [49] Interaction between cerebrovascular disease and Alzheimer pathology
    Saito, Satoshi
    Ihara, Masafumi
    CURRENT OPINION IN PSYCHIATRY, 2016, 29 (02) : 168 - 173
  • [50] Mediterranean diet and structural neuroimaging biomarkers of Alzheimer's and cerebrovascular disease: A systematic review
    Gregory, Sarah
    Pullen, Hannah
    Ritchie, Craig W.
    Shannon, Oliver M.
    Stevenson, Emma J.
    Muniz-Terrera, Graciela
    EXPERIMENTAL GERONTOLOGY, 2023, 172